$QRVO
Qorvo Inc

2024 Q1 Form 10-Q Financial Statement

#000160477824000018 Filed on February 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4
Revenue $941.0M $1.074B
YoY Change -7.27%
Cost Of Revenue $559.1M $686.0M
YoY Change 10.8%
Gross Profit $381.9M $387.9M
YoY Change -28.03%
Gross Profit Margin 40.58% 36.12%
Selling, General & Admin $87.95M $86.91M
YoY Change -11.09%
% of Gross Profit 23.03% 22.41%
Research & Development $179.9M $164.3M
YoY Change -2.28%
% of Gross Profit 47.11% 42.37%
Depreciation & Amortization $5.156M $78.85M
YoY Change -6.91%
% of Gross Profit 1.35% 20.33%
Operating Expenses $351.9M $429.4M
YoY Change 54.83%
Operating Profit $29.98M -$41.57M
YoY Change -115.89%
Interest Expense -$17.28M $17.58M
YoY Change 4.0%
% of Operating Profit -57.65%
Other Income/Expense, Net $16.82M $15.36M
YoY Change 593.72%
Pretax Income $29.51M -$43.79M
YoY Change -117.74%
Income Tax $26.78M $83.10M
% Of Pretax Income 90.73%
Net Earnings $2.735M -$126.9M
YoY Change -167.3%
Net Earnings / Revenue 0.29% -11.82%
Basic Earnings Per Share -$1.31
Diluted Earnings Per Share $0.03 -$1.31
COMMON SHARES
Basic Shares Outstanding 96.55M shares 97.35M shares
Diluted Shares Outstanding 97.15M shares

Balance Sheet

Concept 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.029B $1.072B
YoY Change 17.6%
Cash & Equivalents $1.029B $1.072B
Short-Term Investments
Other Short-Term Assets $293.3M $75.45M
YoY Change 44.95%
Inventory $710.6M $726.7M
Prepaid Expenses $40.56M $39.58M
Receivables $413.0M $483.8M
Other Receivables $0.00 $30.86M
Total Short-Term Assets $2.446B $2.428B
YoY Change -3.69%
LONG-TERM ASSETS
Property, Plant & Equipment $871.0M $1.039B
YoY Change -15.0%
Goodwill $2.535B $2.540B
YoY Change -7.86%
Intangibles $509.4M $500.0M
YoY Change -14.66%
Long-Term Investments $23.25M $17.50M
YoY Change -31.37%
Other Assets $170.4M $166.4M
YoY Change -35.51%
Total Long-Term Assets $4.109B $4.271B
YoY Change -12.0%
TOTAL ASSETS
Total Short-Term Assets $2.446B $2.428B
Total Long-Term Assets $4.109B $4.271B
Total Assets $6.555B $6.699B
YoY Change -9.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $589.8M $283.0M
YoY Change -12.19%
Accrued Expenses $336.8M $327.5M
YoY Change 9.57%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $438.7M $480.0M
YoY Change 83956.74%
Total Short-Term Liabilities $1.230B $1.280B
YoY Change 67.56%
LONG-TERM LIABILITIES
Long-Term Debt $1.549B $1.550B
YoY Change -24.27%
Other Long-Term Liabilities $218.9M $230.3M
YoY Change -4.48%
Total Long-Term Liabilities $1.768B $1.781B
YoY Change -22.19%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.230B $1.280B
Total Long-Term Liabilities $1.768B $1.781B
Total Liabilities $2.998B $3.061B
YoY Change 0.28%
SHAREHOLDERS EQUITY
Retained Earnings -$89.60M -$92.33M
YoY Change -120.61%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.556B $3.638B
YoY Change
Total Liabilities & Shareholders Equity $6.555B $6.699B
YoY Change -9.16%

Cashflow Statement

Concept 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income $2.735M -$126.9M
YoY Change -167.3%
Depreciation, Depletion And Amortization $5.156M $78.85M
YoY Change -6.91%
Cash From Operating Activities $202.3M $492.9M
YoY Change 84.34%
INVESTING ACTIVITIES
Capital Expenditures $32.72M $26.41M
YoY Change -156.2%
Acquisitions
YoY Change
Other Investing Activities -$80.46M $27.32M
YoY Change 1592.87%
Cash From Investing Activities -$113.2M $909.0K
YoY Change -102.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -131.7M -113.6M
YoY Change -32.01%
NET CHANGE
Cash From Operating Activities 202.3M 492.9M
Cash From Investing Activities -113.2M 909.0K
Cash From Financing Activities -131.7M -113.6M
Net Change In Cash -42.56M 380.3M
YoY Change 591.26%
FREE CASH FLOW
Cash From Operating Activities $202.3M $492.9M
Capital Expenditures $32.72M $26.41M
Free Cash Flow $169.6M $466.5M
YoY Change 48.38%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Long Term Investments
LongTermInvestments
20406000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
166443000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
193381000 usd
CY2023Q4 us-gaap Assets
Assets
6699388000 usd
CY2023Q2 us-gaap Assets
Assets
6691903000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
282954000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
210701000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
327485000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
222463000 usd
CY2023Q4 us-gaap Revenues
Revenues
1073861000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
432000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
369000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2017964000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1900317000 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
405000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
405000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
96680000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
98649000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
96680000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
98649000 shares
CY2023Q4 us-gaap Assets Current
AssetsCurrent
2428368000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
2029794000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1039439000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1149806000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
2540461000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
2760813000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
499963000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
537703000 usd
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
24714000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
479964000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
310000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
189930000 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
122289000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1280333000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
555763000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1550438000 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2048073000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
230270000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
185273000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
3061041000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
2789109000 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
3730577000 usd
CY2023Q2 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
3821474000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
102000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3175000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-92332000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
84495000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
3638347000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
3902794000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6699388000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6691903000 usd
CY2022Q4 us-gaap Revenues
Revenues
743281000 usd
us-gaap Revenues
Revenues
2828518000 usd
us-gaap Revenues
Revenues
2936696000 usd
CY2023Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
685983000 usd
CY2022Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
475230000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1721880000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1754468000 usd
CY2023Q4 us-gaap Gross Profit
GrossProfit
387878000 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
268051000 usd
us-gaap Gross Profit
GrossProfit
1106638000 usd
us-gaap Gross Profit
GrossProfit
1182228000 usd
CY2023Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
164329000 usd
CY2022Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
149472000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
502366000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
486204000 usd
CY2023Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
86914000 usd
CY2022Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
76269000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
296033000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
275836000 usd
CY2023Q4 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
178204000 usd
CY2022Q4 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
33581000 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
246516000 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
48038000 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
429447000 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
259322000 usd
us-gaap Operating Expenses
OperatingExpenses
1044915000 usd
us-gaap Operating Expenses
OperatingExpenses
810078000 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-41569000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
8729000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
61723000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
372150000 usd
CY2023Q4 us-gaap Interest Expense
InterestExpense
17581000 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
17066000 usd
us-gaap Interest Expense
InterestExpense
51963000 usd
us-gaap Interest Expense
InterestExpense
51222000 usd
CY2023Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15359000 usd
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5562000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
34286000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2714000 usd
CY2023Q4 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-43791000 usd
CY2022Q4 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-2775000 usd
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
44046000 usd
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
323642000 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
83147000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13156000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-126938000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.34
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.75
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.33
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100943000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
97905000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
103039000 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
97152000 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100943000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
97905000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
103812000 shares
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-126938000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-15931000 usd
us-gaap Net Income Loss
NetIncomeLoss
-73057000 usd
us-gaap Net Income Loss
NetIncomeLoss
241568000 usd
CY2022Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
30403000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
3286000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-16623000 usd
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
-26000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3277000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-16597000 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
14480000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-69780000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
224971000 usd
CY2023Q3 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
3796189000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-13609000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
34606000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3817186000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-126938000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
13711000 usd
CY2023Q4 rfmd Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes
ExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsNetOfSharesWithheldForEmployeeTaxes
847000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
15865000 usd
CY2023Q4 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
100812000 usd
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
20182000 usd
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
96680000 shares
CY2023Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
3730577000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
102000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-92332000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
3638347000 usd
CY2022Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
3915969000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-41776000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
447947000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
4322140000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-15931000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
30411000 usd
CY2022Q4 rfmd Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes
ExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsNetOfSharesWithheldForEmployeeTaxes
321000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
11276000 usd
CY2022Q4 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
201633000 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18626000 usd
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100021000 shares
CY2022Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
3859940000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-11365000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
315993000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
4164568000 usd
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
98649000 shares
CY2023Q2 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
3821474000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3175000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
84495000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
3902794000 usd
us-gaap Net Income Loss
NetIncomeLoss
-73057000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3277000 usd
rfmd Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes
ExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsNetOfSharesWithheldForEmployeeTaxes
25010000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
35045000 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
301978000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
97276000 usd
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
96680000 shares
CY2023Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
3730577000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
102000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-92332000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
3638347000 usd
CY2022Q2 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
4035849000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5232000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
512137000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
4553218000 usd
us-gaap Net Income Loss
NetIncomeLoss
241568000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-16597000 usd
rfmd Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes
ExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsNetOfSharesWithheldForEmployeeTaxes
21502000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
30169000 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
711732000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
89444000 usd
CY2022Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
3859940000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-11365000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
315993000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
4164568000 usd
us-gaap Net Income Loss
NetIncomeLoss
-73057000 usd
us-gaap Net Income Loss
NetIncomeLoss
241568000 usd
us-gaap Depreciation
Depreciation
146841000 usd
us-gaap Depreciation
Depreciation
155132000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
92308000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
99476000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
62365000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2557000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
221414000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
99253000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
86911000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
24453000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
95459000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
179315000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-201823000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-66190000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
98882000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
10312000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-42979000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
183091000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-85321000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-9408000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-17281000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
7022000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
58481000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
630845000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
777788000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
94514000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
124853000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
47446000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
581000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-23777000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-6914000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23291000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-117358000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
300043000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
711732000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
26358000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
20828000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
26318000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
22687000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
17914000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
0 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-9933000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-422000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-327850000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-714013000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3340000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-280000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
283044000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-53863000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
808943000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
972805000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1091987000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1071987000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
918758000 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
20000000 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
184000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
214530000 usd
CY2023Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
264367000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
372554000 usd
CY2023Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
345545000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
139603000 usd
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
186684000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
726687000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
796596000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
2760813000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
221414000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
1062000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
2540461000 usd
CY2023Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
903400000 usd
CY2023Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
682000000 usd
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
48000000 usd
CY2023Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
173400000 usd
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1028132000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
528169000 usd
CY2023Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
988938000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
451235000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
17500000 usd
CY2023Q2 us-gaap Equity Method Investments
EquityMethodInvestments
20400000 usd
CY2023Q4 us-gaap Gain Loss On Investments
GainLossOnInvestments
600000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
300000 usd
CY2022Q4 us-gaap Gain Loss On Investments
GainLossOnInvestments
5000000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
4700000 usd
CY2023Q4 us-gaap Proceeds From Limited Partnership Investments
ProceedsFromLimitedPartnershipInvestments
400000 usd
us-gaap Proceeds From Limited Partnership Investments
ProceedsFromLimitedPartnershipInvestments
3200000 usd
CY2022Q4 us-gaap Proceeds From Limited Partnership Investments
ProceedsFromLimitedPartnershipInvestments
200000 usd
us-gaap Proceeds From Limited Partnership Investments
ProceedsFromLimitedPartnershipInvestments
2200000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
2186000 usd
CY2023Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
3283000 usd
CY2023Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
2030402000 usd
CY2023Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
2048383000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
479964000 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
310000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
1550438000 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
2048073000 usd
CY2020Q3 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
500000000 usd
CY2023Q4 us-gaap Debt Instrument Repurchased Face Amount
DebtInstrumentRepurchasedFaceAmount
18700000 usd
CY2023Q4 us-gaap Gain Loss On Repurchase Of Debt Instrument
GainLossOnRepurchaseOfDebtInstrument
700000 usd
CY2023Q4 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
18200000 usd
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
54200000 usd
CY2023Q4 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
600000 usd
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
2300000 usd
CY2022Q4 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
18100000 usd
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
54200000 usd
CY2022Q4 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
1000000 usd
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
3000000 usd
CY2023Q4 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
1100000 shares
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
3100000 shares
CY2023Q4 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
100800000 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
302000000 usd
CY2023Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
1405000000 usd
CY2022Q4 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
2200000 shares
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
7200000 shares
CY2022Q4 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
201600000 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
711700000 usd
CY2022Q3 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
110000000 usd
us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 usd
CY2023Q4 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
65000000 usd
CY2023Q4 us-gaap Revenues
Revenues
1073861000 usd
CY2022Q4 us-gaap Revenues
Revenues
743281000 usd
us-gaap Revenues
Revenues
2828518000 usd
us-gaap Revenues
Revenues
2936696000 usd
CY2023Q2 us-gaap Restructuring Reserve
RestructuringReserve
5248000 usd
us-gaap Restructuring Charges
RestructuringCharges
28443000 usd
us-gaap Payments For Restructuring
PaymentsForRestructuring
19175000 usd
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
14516000 usd
CY2023Q4 us-gaap Revenues
Revenues
1073861000 usd
CY2022Q4 us-gaap Revenues
Revenues
743281000 usd
us-gaap Revenues
Revenues
2828518000 usd
us-gaap Revenues
Revenues
2936696000 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-41569000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
8729000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
61723000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
372150000 usd
CY2023Q4 us-gaap Interest Expense
InterestExpense
17581000 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
17066000 usd
us-gaap Interest Expense
InterestExpense
51963000 usd
us-gaap Interest Expense
InterestExpense
51222000 usd
CY2023Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15359000 usd
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5562000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
34286000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2714000 usd
CY2023Q4 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-43791000 usd
CY2022Q4 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-2775000 usd
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
44046000 usd
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
323642000 usd
CY2023Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
173414000 usd
CY2022Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
221414000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
83100000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
117100000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13200000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
82100000 usd
CY2023Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-1.899 rate
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
2.659 rate
CY2022Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-4.741 rate
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.254 rate
CY2023Q4 rfmd Discretetaxexpensebenefit
Discretetaxexpensebenefit
40200000 usd
rfmd Discretetaxexpensebenefit
Discretetaxexpensebenefit
45700000 usd
CY2022Q4 rfmd Discretetaxexpensebenefit
Discretetaxexpensebenefit
2200000 usd
rfmd Discretetaxexpensebenefit
Discretetaxexpensebenefit
-10400000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-126938000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-15931000 usd
us-gaap Net Income Loss
NetIncomeLoss
-73057000 usd
us-gaap Net Income Loss
NetIncomeLoss
241568000 usd
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
97152000 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100943000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
97905000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
103039000 shares
CY2023Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2022Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
773000 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
97152000 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100943000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
97905000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
103812000 shares
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.31
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.75
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.34
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.31
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.75
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.33
CY2023Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2200000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1600000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
900000 shares
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001604778-24-000018-index-headers.html Edgar Link pending
0001604778-24-000018-index.html Edgar Link pending
0001604778-24-000018.txt Edgar Link pending
0001604778-24-000018-xbrl.zip Edgar Link pending
exhibit2220231230.htm Edgar Link pending
exhibit31120231230.htm Edgar Link pending
exhibit31220231230.htm Edgar Link pending
exhibit32120231230.htm Edgar Link pending
exhibit32220231230.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rfmd-20231230.htm Edgar Link pending
rfmd-20231230.xsd Edgar Link pending
rfmd-20231230_g1.jpg Edgar Link pending
Show.js Edgar Link pending
rfmd-20231230_cal.xml Edgar Link unprocessable
rfmd-20231230_def.xml Edgar Link unprocessable
rfmd-20231230_lab.xml Edgar Link unprocessable
rfmd-20231230_pre.xml Edgar Link unprocessable
rfmd-20231230_htm.xml Edgar Link completed